• Organization: U.S. Department of Health & Human Services
• Updated: 2025-09-06

Background GPIIb/IIIa inhibitors abciximab and eptifibatide have been shown to inhibit platelet aggregation in ischemic heart disease. Our aim was to test the efficacy of abiciximab (Reo...

• html

• Organization: U.S. Department of Health & Human Services
• Updated: 2025-03-17

Kengreal (cangrelor) is an intravenous antiplatelet medication that works by inhibiting platelet aggregation to reduce the risk of blood clots during certain heart procedures. It's supplied as a...

• html

• Organization: U.S. Department of Health & Human Services
• Updated: 2025-03-17

Vazalore is an over-the-counter aspirin medication from PLx Pharma Inc., available in 81mg and 325mg oral capsules. It acts as a nonsteroidal anti-inflammatory drug and platelet aggregation...

• html

• Organization: U.S. Department of Health & Human Services
• Updated: 2025-03-17

Plavix (clopidogrel) is a prescription medication that helps prevent blood clots by inhibiting platelet aggregation. It's available as oral tablets in 75 mg and 300 mg strengths, manufactured by...

• html

• Organization: U.S. Department of Health & Human Services
• Updated: 2025-03-17

Ticagrelor is a prescription medication that helps prevent blood clots by reducing platelet aggregation. It's available as 60 mg and 90 mg oral tablets, used to lower the risk of heart attack or...

• html

• Organization: U.S. Department of Health & Human Services
• Updated: 2025-03-17

Prasugrel is a prescription medication that prevents blood clots by inhibiting platelet aggregation, reducing the risk of heart attack or stroke in patients with acute coronary syndromes....

• html

• Organization: U.S. Department of Health & Human Services
• Updated: 2025-03-17

Eptifibatide is an injectable medication that prevents blood clots by inhibiting platelet aggregation. It's administered intravenously and used to treat acute coronary syndromes, reducing the risk...

• html

• Organization: U.S. Department of Health & Human Services
• Updated: 2025-09-06

Novel 1,5-benzothiazepine derivatives of the formula:wherein R1 is hydrogen or lower alkyl, R2 is hydrogen, lower alkanoyl or benzyl, R3 is hydrogen or lower alkyl and either one of R4 and R5 is...

• html

• Organization: U.S. Department of Health & Human Services
• Updated: 2025-09-06

Novel 1,5-benzothiazepine derivatives of the formula:wherein R' and R4 are:a) R1 is lower alkyl or lower alkoxy, and R4 is lower alkyl, lower alkoxy, fluorine, benzyloxy, hydroxy or lower...

• html

• Organization: U.S. Department of Health & Human Services
• Updated: 2025-09-06

Background Although all patients undergoing total joint arthroplasty are subjected to similar risk factors that predispose to thromboembolism, only a subset of patients develop this...

• html